Exclusive-Merck Vaccine Case Linked to HHS Secretary Kennedy Delayed Mid-Trial
(Reuters) - Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr, the company said.
Merck vaccine delayed mid-trial
Merck & Co.'s first trial over the safety of its blockbuster cancer vaccine Gardasil was postponed mid-trial due to concerns that jurors might be influenced by media coverage surrounding the confirmation of Robert F. Kennedy Jr. as HHS Secretary, Bloomberg reported Feb. 18.
Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public ...
18don MSN
Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.
Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader ...
RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, ...
They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...
Recently appointed HHS Secretary Robert F. Kennedy Jr. in 2018 helped bring several cases against vaccine maker Merck, ...
Merck and a plaintiff have paused a trial over potential Gardasil injuries, with ties to Health Secretary Robert F. Kennedy Jr. The trial resumes in September. Kennedy, involved in mass litigation ...
The secretary of Health and Human Services nominee wrote in an ethics agreement that he would keep receiving contingency fees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback